Ctrl Worx Watch List › Company
Repligen Corp (RGEN): material weakness open 1,308 days
By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.
Repligen Corp reported ineffective internal control over financial reporting because of a material weakness in 11 filings since Feb 22, 2024. It stated one or more material weaknesses in 6 more SEC filings that gave no conclusion on whether that control is effective. The latest was its 10-Q for the period ended Jun 30, 2026.
Ctrl Worx Watch List™ status
On the ClockStill filing, and no annual report of its own says the weakness is fixed.
Checked against SEC EDGAR: Oct 29, 2026 · Entry #10085
Causes the company named
Not described · 10Revenue recognition · 4Financial close and reporting · 2ITGC: user access · 2ITGC: change management · 2Inventory · 2Complex or non-routine accounting · 2Accounting expertise and resources · 1Entity-level and governance · 1
What the latest filing says
Based on such evaluation, the principal executive officer and principal financial officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were not effective because of the previously reported material weaknesses in our internal control over financial reporting, which are described in [...]
From the controls section of the 10-Q filed Jul 29, 2026. Read the full filing on SEC EDGAR.
Company response: Repligen Corp can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.
Filings
| Filed | Form | Period | Controls | Causes | Filing |
|---|---|---|---|---|---|
| Jul 29, 2026 | 10-Q | Jun 30, 2026 | Material weakness stated, no ICFR conclusion | Financial close and reporting; ITGC: user access; ITGC: change management; Inventory | EDGAR |
| May 6, 2026 | 10-Q | Mar 31, 2026 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Feb 26, 2026 | 10-K | Dec 31, 2025 | Not effective | Financial close and reporting; ITGC: user access; ITGC: change management; Revenue recognition; Inventory | EDGAR |
| Nov 4, 2025 | 10-Q | Sep 30, 2025 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Aug 7, 2025 | 10-Q | Jun 30, 2025 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Apr 29, 2025 | 10-Q | Mar 31, 2025 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Mar 14, 2025 | 10-K | Dec 31, 2024 | Not effective | Accounting expertise and resources; Complex or non-routine accounting | EDGAR |
| Nov 18, 2024 | 10-Q | Sep 30, 2024 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Nov 18, 2024 | 10-Q/A | Jun 30, 2024 | Not effective | Not described | EDGAR |
| Jul 30, 2024 | 10-Q | Jun 30, 2024 | Not effective | Not described | EDGAR |
| Nov 18, 2024 | 10-Q/A | Mar 31, 2024 | Not effective | Not described | EDGAR |
| May 1, 2024 | 10-Q | Mar 31, 2024 | Not effective | Not described | EDGAR |
| Nov 18, 2024 | 10-K/A | Dec 31, 2023 | Not effective | Not described | EDGAR |
| Feb 22, 2024 | 10-K | Dec 31, 2023 | Not effective | Complex or non-routine accounting; Entity-level and governance | EDGAR |
| Nov 18, 2024 | 10-Q/A | Sep 30, 2023 | Not effective | Revenue recognition | EDGAR |
| Nov 18, 2024 | 10-Q/A | Jun 30, 2023 | Not effective | Revenue recognition | EDGAR |
| Nov 18, 2024 | 10-Q/A | Mar 31, 2023 | Not effective | Revenue recognition | EDGAR |
| Feb 22, 2023 | 10-K | Dec 31, 2022 | Effective | EDGAR | |
| Feb 17, 2022 | 10-K | Dec 31, 2021 | Effective | EDGAR | |
| Feb 24, 2021 | 10-K | Dec 31, 2020 | Effective | EDGAR |
Others on the Clock in the same industry
By SEC industry code: 2836, Biological Products, (No Diagnostic Substances), then related codes.
- Agentix Corp. (AGTX) · open since Mar 2023
- CEL SCI CORP (CVM) · open since Sep 2022
- ADAPTIN BIO, INC. (APTN) · open since Sep 2023
- FutureTech II Acquisition Corp. (FTII) · open since Sep 2023
- Greenland Mines Ltd (GRML) · open since Dec 2023
Follow RGEN for free
Get an email when Repligen Corp files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.
Want the next one the day it's filed?
MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.
Join the MW Pro waitlistLook up any company in Controls Radar™Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Repligen Corp or the SEC. Not investment advice. Why you can rely on the Watch List.